Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Smart Devices, Big Data, and the Value of Long-Term Research

Posted on August 29th, 2016 by in Pharma R&D

In a new feature in The Atlantic, author Jessa Gamble makes the case that Modern Medicine Is Too Reliant on Short-Term Studies, too often preferring the instant gratification that comes from a short study, only to find those results soon challenged by yet another short-term study.

(more…)

How will Brexit effect Multinationals and Pharmaceutical Companies?

Posted on June 30th, 2016 by in Pharma R&D

One of the most stunning upsets to happen in global politics in decades transpired on June 23 when the people of the United Kingdom voted to leave the European Union. (more…)

A Holistic Cure for the Pharmaceutical Industry’s Ailments

Posted on June 17th, 2016 by in Pharma R&D

Since the turn of the century, the pharmaceutical industry has seen dramatic changes, including dwindling drug pipelines, looming patent expirations and rising costs. (more…)

Catalyzing Decisions in Pharma-Biotech Collaborations

Posted on March 4th, 2016 by in Pharma R&D

Despite large strides in technological and scientific progress, the cost to develop and release a new drug has escalated dramatically (1). At the same time, the number of generic drugs has grown in the last decade (2). In the U.S., 70% of (more…)

  1. 1
  2. 4
  3. 5
  4. 6